Mirror Now
@mirrornow·2.2M subscribers·145K videos
Covaxin as vaccine for children gets a nod
Posted
October 12, 2021
Views
281
Likes
2
Engagement
0.71%
October 12, 2021
281
2
0.71%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
19:48Now PlayingThe Covid-19 Subject Expert Committee has approved Bharat Biotech's Covaxin for emergency use in children aged 2 to 18. Bharat Biotech, based in Hyderabad, completed Phase 2 and Phase 3 tests of Covaxin on children under the age of 18 in September and submitted the trial results to India's Drugs and Comptroller General (DCGI). Following careful deliberation, the committee recommended that the vaccine be approved for limited use in emergency settings in children aged 2 to 18. The vaccine, which was developed in India, will be administered in two doses with a 20-day interval between them.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
